Skin Efficacy Testing of Astrion Products

NCT06657352 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2024-10-26

No results posted yet for this study

Summary

This project aims to conduct safety and efficacy tests on the skin for the ingestion of Astrion Vitality Capsules, containing A. membranaceus and C. Asiatica roots, and the topical application of Astrion Vitality Cream. The goal is to develop health and skincare products that regulate physiological functions, promote overall wellness, and enhance skin beauty.

Conditions

  • Skin Pigment
  • Skin Red

Interventions

DIETARY_SUPPLEMENT

ACS Topical Treatment Group

The topical group applied the ACS cream to the face twice daily (morning and night) for 4 weeks.

DIETARY_SUPPLEMENT

Topical Placebo Group

The topical group applied the cream (without ACS) to the face twice daily (morning and night) for 4 weeks.

DIETARY_SUPPLEMENT

Oral Treatment + Topical Treatment Group

The combination group used both the topical and oral ACS products for 12 weeks.

DIETARY_SUPPLEMENT

ACS Oral Treatment Group

The oral group ingested one ACS capsule twice daily after breakfast and dinner for 12 weeks.

DIETARY_SUPPLEMENT

Oral Placebo Group

The oral group ingested one capsule (without ACS) twice daily after breakfast and dinner for 12 weeks.

DIETARY_SUPPLEMENT

Oral Treatment + Topical Placebo Group

The combination group used both the topical and oral products without ACS for 12 weeks.

Sponsors & Collaborators

  • Chia Nan University of Pharmacy & Science

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-28
Primary Completion
2023-09-30
Completion
2023-09-30

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06657352 on ClinicalTrials.gov